562 related articles for article (PubMed ID: 18766181)
1. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer.
Michelakis ED; Webster L; Mackey JR
Br J Cancer; 2008 Oct; 99(7):989-94. PubMed ID: 18766181
[TBL] [Abstract][Full Text] [Related]
2. Metabolic targeting as an anticancer strategy: dawn of a new era?
Pan JG; Mak TW
Sci STKE; 2007 Apr; 2007(381):pe14. PubMed ID: 17426345
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
4. Targeted reversal and phosphorescence lifetime imaging of cancer cell metabolism via a theranostic rhenium(I)-DCA conjugate.
Yang J; Cao Q; Zhang H; Hao L; Zhou D; Gan Z; Li Z; Tong YX; Ji LN; Mao ZW
Biomaterials; 2018 Sep; 176():94-105. PubMed ID: 29870900
[TBL] [Abstract][Full Text] [Related]
5. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
Neveu MA; De Preter G; Joudiou N; Bol A; Brender JR; Saito K; Kishimoto S; Grégoire V; Jordan BF; Krishna MC; Feron O; Gallez B
Oncotarget; 2016 Dec; 7(49):81741-81749. PubMed ID: 28082726
[TBL] [Abstract][Full Text] [Related]
6. Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate.
Schoonjans CA; Joudiou N; Brusa D; Corbet C; Feron O; Gallez B
Cancer Lett; 2020 Feb; 470():18-28. PubMed ID: 31812695
[TBL] [Abstract][Full Text] [Related]
7. Dichloroacetate and cancer: new home for an orphan drug?
Kankotia S; Stacpoole PW
Biochim Biophys Acta; 2014 Dec; 1846(2):617-29. PubMed ID: 25157892
[TBL] [Abstract][Full Text] [Related]
8. Targeting of two aspects of metabolism in breast cancer treatment.
Gang BP; Dilda PJ; Hogg PJ; Blackburn AC
Cancer Biol Ther; 2014; 15(11):1533-41. PubMed ID: 25482950
[TBL] [Abstract][Full Text] [Related]
9. Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate.
Pathak RK; Marrache S; Harn DA; Dhar S
ACS Chem Biol; 2014 May; 9(5):1178-87. PubMed ID: 24617941
[TBL] [Abstract][Full Text] [Related]
10. Targeting Glucose Metabolism of Cancer Cells with Dichloroacetate to Radiosensitize High-Grade Gliomas.
Cook KM; Shen H; McKelvey KJ; Gee HE; Hau E
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298883
[TBL] [Abstract][Full Text] [Related]
11. Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC.
Stockwin LH; Yu SX; Borgel S; Hancock C; Wolfe TL; Phillips LR; Hollingshead MG; Newton DL
Int J Cancer; 2010 Dec; 127(11):2510-9. PubMed ID: 20533281
[TBL] [Abstract][Full Text] [Related]
12. Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines.
Tataranni T; Agriesti F; Pacelli C; Ruggieri V; Laurenzana I; Mazzoccoli C; Sala GD; Panebianco C; Pazienza V; Capitanio N; Piccoli C
Cells; 2019 May; 8(5):. PubMed ID: 31109089
[TBL] [Abstract][Full Text] [Related]
13. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1.
James MO; Jahn SC; Zhong G; Smeltz MG; Hu Z; Stacpoole PW
Pharmacol Ther; 2017 Feb; 170():166-180. PubMed ID: 27771434
[TBL] [Abstract][Full Text] [Related]
15. Anticancer drugs that target metabolism: Is dichloroacetate the new paradigm?
Papandreou I; Goliasova T; Denko NC
Int J Cancer; 2011 Mar; 128(5):1001-8. PubMed ID: 20957634
[TBL] [Abstract][Full Text] [Related]
16. Dichloroacetate metabolically targeted therapy defeats cytotoxicity of standard anticancer drugs.
Heshe D; Hoogestraat S; Brauckmann C; Karst U; Boos J; Lanvers-Kaminsky C
Cancer Chemother Pharmacol; 2011 Mar; 67(3):647-55. PubMed ID: 20502900
[TBL] [Abstract][Full Text] [Related]
17. Lipoic acid inhibits cell proliferation of tumor cells in vitro and in vivo.
Feuerecker B; Pirsig S; Seidl C; Aichler M; Feuchtinger A; Bruchelt G; Senekowitsch-Schmidtke R
Cancer Biol Ther; 2012 Dec; 13(14):1425-35. PubMed ID: 22954700
[TBL] [Abstract][Full Text] [Related]
18. [Anti-cancer properties of dichloroacetate].
Latocha M; Żyrek L
Pol Merkur Lekarski; 2022 Apr; 50(296):145-147. PubMed ID: 35436282
[TBL] [Abstract][Full Text] [Related]
19. Dichloroacetate improves postischemic function of hypertrophied rat hearts.
Wambolt RB; Lopaschuk GD; Brownsey RW; Allard MF
J Am Coll Cardiol; 2000 Oct; 36(4):1378-85. PubMed ID: 11028498
[TBL] [Abstract][Full Text] [Related]
20. Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology.
Sutendra G; Michelakis ED
Front Oncol; 2013; 3():38. PubMed ID: 23471124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
